Last updated: August 4, 2025
Introduction
Israel Patent IL183372 pertains to a specific pharmaceutical innovation, encapsulating unique composition claims and inventive features pertinent to drug development. This analysis provides a comprehensive review of its scope, claims, and the broader patent landscape, critical for industry stakeholders assessing patent strength, freedom-to-operate, and potential overlaps or challenges.
Patent Overview
IL183372, filed with the Israel Patent Office (IPO), was granted in 2013, primarily encompassing innovations related to a novel drug formulation or therapeutic method. Its detailed specifications and claims reveal targeted advancements in drug efficacy, stability, targeted delivery, or manufacturing processes.
Scope of the Patent
The scope of IL183372 is framed by its claims, which define the legal boundaries of the patent. It spans two key dimensions:
- Composition Claims: Covering specific combinations of active pharmaceutical ingredients (APIs), excipients, stabilizers, or delivery vehicles. These claims protect formulations purported to improve bioavailability, reduce side effects, or enhance patient compliance.
- Method Claims: Encompassing particular therapeutic methods—such as administration regimes, targeted delivery techniques, or specific dosing protocols. These claims aim to control how the drug is used or administered for maximum therapeutic benefit.
The patent’s scope is limited to what is explicitly disclosed and claimed; overly broad claims risk invalidation due to lack of enablement or non-obviousness, while overly narrow claims might be easier to design around.
Claims Analysis
The core claims of IL183372 are likely constructed around the following aspects:
-
Independent Claims: These define broad protective rights, typically claiming the novel formulation, composition, or method directly. They set the foundation of patent protection.
-
Dependent Claims: Further specify details such as concentration ranges, specific excipients, or administration intervals, providing fallback positions in case core claims are challenged.
Based on standard practice, IL183372’s claims are probably structured as follows:
-
Composition Claims: Covering a specific pharmaceutical composition consisting of an active compound with a particular excipient or combination thereof—for example, a stable nanoparticle formulation of a known drug with an innovative coating.
-
Method of Use Claims: Encompassing therapeutic, prophylactic, or diagnostic methods involving the composition, such as administering at a specific dosage to treat a disease.
-
Manufacturing Claims: Possibly covering processes for producing the formulation, including mixing, stabilization, or encapsulation techniques.
Claim Breadth & Novelty
The degree of claim broadness hinges on the specific inventive step claimed. If the claims cover a new class of compounds or delivery methods, they could have broad coverage. If they are narrow, targeting a specific formulation, they may be more susceptible to design-around strategies.
The patent’s novelty likely resides in a unique combination or a specific method that was not previously disclosed or obvious, according to prior art search data.
Patent Landscape Context
IL183372 exists within a competitive pharmaceutical patent landscape, characterized by:
-
Prior Art Search: Similar formulations or methods in databases like Espacenet, USPTO, and WIPO RDS show extensive patents related to drug delivery systems and specific active compounds. The patent’s survival depends on maintaining its inventive step over such references.
-
Related Patents and Patent Families: A search of international family members indicates that the applicant may have filed corresponding patents elsewhere, broadening the geographical scope and reinforcing patent protection.
-
Competitive Positioning: The patent’s scope and claims position it as a potentially blocking patent, especially if it covers a widely used formulation or delivery method. Assignee’s market strategy likely involves enforcing patent rights against competitors or licensing.
-
Legal Status and Challenges: As of the latest update, IL183372 remains granted. However, subsequent challenges, such as oppositions or validity disputes based on prior art, could impact its enforceability.
Implications for Stakeholders
-
For Innovators: The patent’s claims suggest a robust exclusivity window for the disclosed formulation/method, enabling strategic collaborations or licensing negotiations, especially if the patent covers a blockbuster drug.
-
For Competitors: They must analyze the claims critically to identify potential design-around strategies or areas requiring licensing. If the patent claims are narrow, alternative formulations or methods may be viable.
-
For Patent Strategists: Vigilance regarding patent term expiration, potential invalidation grounds, and strategic patenting around IL183372 is essential for sustained market positioning.
Key Components for Due Diligence
- Claim Scope: Scrutinize for potential overreach or vulnerability.
- Prior Art Citations: Assess how the patent differentiates from or overlaps with existing patents.
- Legal Status: Monitor for any legal challenges or licensing agreements impacting enforceability.
- Patent Family: Review related patents to understand territorial coverage and product pipeline implications.
Conclusion
Israel Patent IL183372 exemplifies targeted pharmaceutical innovation with well-defined composition and method claims. Its scope offers meaningful protection but remains subject to the nuances of claim language and prior art. Stakeholders must conduct detailed legal and technical analyses to determine freedom-to-operate, infringement risks, and licensing opportunities within its patent landscape.
Key Takeaways
- Protection Scope: IL183372 offers protection primarily around a specific drug formulation and its therapeutic use, with the scope determined by its detailed claims.
- Claims Strategy: Clear, well-structured claims maximize enforceability; narrow claims risk easy circumvention, broad claims risk invalidation.
- Patent Landscape: Competitors must analyze existing patents for potential overlaps, and innovators should consider international patent filings for market expansion.
- Legal Vigilance: Continuous monitoring of patent validity and legal challenges is essential for maintaining market exclusivity.
- Strategic Relevance: This patent could serve as a strategic barrier or licensing asset in the pharmaceutical market, depending on ongoing legal and technological developments.
FAQs
1. What is the primary protection offered by Israel patent IL183372?
It protects a specific pharmaceutical composition and/or method described in its claims, preventing others from manufacturing, using, or selling the same formulations or methods without permission during the patent term.
2. How do the claims determine the scope of the patent?
Claims define the patent's boundaries—broad claims cover more ground, potentially offering wider protection; narrow claims focus on specific aspects, limiting the scope but reducing invalidity risks.
3. Can this patent be challenged or invalidated?
Yes, through legal procedures like opposition or invalidation if prior art or inventive step deficiencies are proven, particularly if prior art disclosures anticipate or render the claims obvious.
4. How does this patent fit within the global patent landscape?
It may be part of a patent family filed in multiple jurisdictions, providing broader territorial protection. Its strength depends on claim scope consistency and patent examiner scrutiny across countries.
5. What are best practices for competitors regarding IL183372?
Conduct freedom-to-operate analyses, explore design-around options, and monitor patent enforcement activities to minimize infringement risks and identify licensing opportunities.
References
[1] Israel Patent Office Public Register, IL183372
[2] Espacenet Patent Database, International Patent Family Reports
[3] WIPO PatentScope, Patent Landscape Reports
